Safety and clinical activity of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in combination with ipilimumab in patients (pts) with advanced melanoma (MEL).
暂无分享，去创建一个
C. Horak | J. Wolchok | M. Sznol | N. Rizvi | N. Segal | H. Kluger | M. Callahan | M. Postow | A. Lesokhin | R. Gordon | Kathleen Reed | M. Burke | A. Caldwell | S. Kronenberg | B. Agunwamba | W. Feely | Q. Hong | A. Korman | J. Wigginton | A. Gupta